ANI Pharmaceuticals Inc
NASDAQ:ANIP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
US |
|
P
|
PacRay International Holdings Ltd
HKEX:1010
|
HK |
|
Fortune Brands Innovations Inc
NYSE:FBIN
|
US |
|
P
|
PPAP Automotive Ltd
NSE:PPAP
|
IN |
|
Centrepoint Alliance Ltd
ASX:CAF
|
AU |
|
EUCALIA Inc
TSE:286A
|
JP |
|
L
|
Lake Victoria Mining Company Inc
OTC:LVCA
|
CA |
|
NetApp Inc
NASDAQ:NTAP
|
US |
|
G
|
Gulshan Polyols Ltd
NSE:GULPOLY
|
IN |
|
B
|
Bindi Metals Ltd
ASX:BIM
|
AU |
|
P
|
Puig Brands SA
MAD:PUIG
|
ES |
|
Scansource Inc
NASDAQ:SCSC
|
US |
|
ArcBest Corp
NASDAQ:ARCB
|
US |
Wall Street
Price Targets
ANIP Price Targets Summary
ANI Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ANIP
is 112.2 USD
with a low forecast of 90.9 USD and a high forecast of 130.2 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ANIP's stock price target?
Price Target
112.2
USD
According to Wall Street analysts, the average 1-year price target for
ANIP
is 112.2 USD
with a low forecast of 90.9 USD and a high forecast of 130.2 USD.
What is ANI Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
16%
For the last 14 years the
compound annual growth rate for
ANI Pharmaceuticals Inc's revenue is
73%.
The projected
CAGR
for the next 3 years is
16%.
What is ANI Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
51%
The
compound annual growth rate
of ANI Pharmaceuticals Inc's operating income for the next 3 years is
51%.
What is ANI Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
55%
The
compound annual growth rate
of ANI Pharmaceuticals Inc's net income for the next 3 years is
55%.
